eGenesis (Series D)

Funding Details
Awarder
Inbox
Date Award
June 09, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$191,000,000

Company Info
Company Description
eGenesis is a biotechnology company developing human-compatible engineered organs to address the global organ shortage.
Market
Organ transplantation
Location
Cambridge, MA, USA
Coinvestors
ARCH Ventures, Khosla Ventures, Farallon Capital Management, Alta Partners, Fresenius Medical Care Ventures, Leaps by Bayer, DaVita, Eisai Innovation, NATCO Pharmaceuticals, Parkwood Corporation

Links